<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03168724</url>
  </required_header>
  <id_info>
    <org_study_id>MUHC-16-031</org_study_id>
    <nct_id>NCT03168724</nct_id>
  </id_info>
  <brief_title>Goal Management Training, Executive Functions and HIV</brief_title>
  <official_title>Efficacy Potential of Goal Management Training to Improve Cognitive Function in Older People Living With HIV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Goal Management Training (GMT) is a cognitive rehabilitation program targeting executive
      dysfunction (problems with attention, reasoning, problem solving, planning, etc), which is a
      central problem in HIV-associated neurocognitive disorder. It teaches self-management
      principles, stress management and mindfulness, and trains participants in the use of several
      strategies to reduce cognitive load in everyday tasks, and methods to cue attention to
      maintain focus on specific tasks. GMT is a manualized protocol with set content conveyed
      through a combination of slides and a workbook. Two-hour small group sessions are led, in
      person, by a trained therapist once a week, for nine weeks. The small group sessions allow
      participants to learn from each other, enhancing engagement. GMT has been shown to improve
      cognitive function in a variety of neurological conditions, as well as in healthy older
      people with cognitive concerns. These improvements have been shown to last at least 6 months
      in some studies and are accompanied by changes in the brain networks underlying executive
      function. GMT is thus a well-validated, high yield intervention with which to test the
      potential of cognitive rehabilitation in older HIV+ people with cognitive concerns.

      The researchers hypothesize that GMT will lead to improved cognitive function as assessed by
      better performance on cognitive tests and reduced self-reported cognitive difficulties in
      people with stable HIV infection who report cognitive difficulties at baseline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rehabilitation is a well-established approach to maintain function in the face of chronic
      disease, and holds promise for addressing the health challenges faced by older people with
      HIV. A Canadian-led knowledge synthesis review published in 2014 identified cognitive
      rehabilitation as a promising approach in HIV, but highlighted the absence of high quality,
      HIV-specific evidence in this area. A recent focused review also highlights the dearth of
      evidence on this topic. Very few studies have been published, and to date all have been
      restricted to computerized training programs only. While there is limited evidence for
      computerized cognitive rehabilitation in any context, there is better evidence for more
      conventional, in-person rehabilitation approaches, at least in other neurological disorders.
      Although computerized training is appealing because it is more feasible to deliver on a wide
      scale than conventional cognitive rehabilitation, The researchers propose that the first step
      should be to establish an evidence base regarding the efficacy of any form of cognitive
      rehabilitation in HIV. Evidence of efficacy of a 'high dose' established rehabilitation
      method could be followed by work to define the key elements, and to study how those elements
      could be delivered most cost-effectively, but there is no point in pursuing these secondary
      steps if the most well-established cognitive rehabilitation approaches do not show efficacy.
      Thus, the researchers propose to test conventional rehabilitation as a crucial first step is
      a research program focused on evidence-based interventions for improving brain health in HIV.

      There is no gold standard conventional cognitive rehabilitation program, but most existing
      approaches combine face-to-face therapy with at home practice over a period of at least
      several weeks. In the absence of a gold standard, the researchers have selected one such
      program: Goal Management Training (GMT). This program targets executive dysfunction, which is
      a central problem in HIV-associated neurocognitive disorder. GMT is grounded in a
      neurobiological framework and was developed based on nearly two decades of research on
      practical approaches to minimizing the impact of executive dysfunction, aiming to help people
      with brain injury manage real life tasks. The program teaches self-management principles,
      stress management and mindfulness, and trains participants in the use of several explicit
      strategies to reduce cognitive load in everyday tasks, and methods to cue attention to
      maintain focus on specific tasks. GMT is a manualized protocol with set content conveyed
      through a combination of slides and a workbook. Two-hour small group sessions are led, in
      person, by a trained therapist once a week, for seven weeks. The small group sessions allow
      participants to learn from each other, enhancing engagement. GMT has been shown to improve
      cognitive function in a variety of neurological conditions, as well as in healthy older
      people with cognitive concerns. Evidence from randomized trials shows that this intervention
      leads to (i) significant improvements in performance on cognitive tests, including
      naturalistic tests of real life tasks, (ii) reduced self-reported cognitive difficulties, and
      (iii) significant improvements in everyday function compared to either a wait-list condition
      or a general brain health education control. Positive effects have been found in older people
      with cognitive difficulties, and neurological populations with mild cognitive impairment
      including mild traumatic brain injury, stroke and spina bifida. These improvements have been
      shown to last at least 6 months in some studies and are accompanied by changes in the brain
      networks underlying executive function. GMT is thus a well-validated, high yield intervention
      with which to test the potential of cognitive rehabilitation in older HIV+ people with
      cognitive concerns.

      The pilot project is nested within an ongoing observational cohort study that aims to
      understand and address the heterogeneous, multi-factorial nature of compromised brain health
      in people living with HIV. Study participants will be randomly selected from those
      participating in the ongoing, longitudinal Positive Brain Health Now (+BHN) study at 2 sites
      in Montreal (The Montreal Chest Institute and L'Actuel Medical Clinic). This CIHR Team
      Grant-supported observational, prospective cohort study has enrolled 840 consecutive patients
      attending 5 HIV clinics across Canada, who are followed every 9 months for 27 months.

      Procedure Participants will be recruited either at the time of their routine +BHN study
      visit, or by phone or by email. Informed consent will occur with the therapist during the
      first GMT group session during which they will also complete a questionnaire regarding any
      cognitive concerns they may have (Communicating Cognitive Concerns-C3Q). At the end of the
      last GMT session, they will be asked to complete the C3Q again. Then, within 4 weeks of
      completing the GMT program, they will be asked to repeat the B-CAM, coincident with the +BHN
      study visit if timing permits.

      Intervention The standard GMT program lasts 9 weeks and involves 9 weekly 2-hour small group
      sessions led by a trained therapist. It follows a manualized program that teaches
      participants a series of techniques to build attention and executive function, and shows them
      how to implement these techniques in their everyday life. The small group sessions allow
      individualization of the training to show how it can be applied to meet the particular
      challenges reported by participants, and explicitly encourage participants to share their
      challenges and successes with others in the group to promote learning and engagement with the
      program. The sessions are reinforced with homework, in which participants practice what they
      have learned. Sessions will be audiotaped for later review by the trainer and/or study
      investigators to ensure adherence to the intervention manual. The material, including
      homework, is provided in a workbook that participants use throughout the training, and keep
      for later reference.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Performance measure (B-CAM)</measure>
    <time_frame>Up to 9 months before the intervention and up to 2 months after the intervention</time_frame>
    <description>We will be looking at changes on the B-CAM (brief cognitive ability measure) pre- and post-intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tower of London (cognitive outcome measure)</measure>
    <time_frame>Up to 9 months before the intervention and up to 2 months after the intervention</time_frame>
    <description>Assesses planning and mental flexibility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Communicating Cognitive Concerns (C3Q)</measure>
    <time_frame>On the first day of the intervention and 9 weeks after the beginning of the intervention</time_frame>
    <description>Evaluates cognitive concerns participants may have</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hiv</condition>
  <arm_group>
    <arm_group_label>GMT Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Over the course of 9 weeks, there are 2h-group sessions with a therapist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Group not getting the intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>GMT intervention</intervention_name>
    <arm_group_label>GMT Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV infection for at least 1 year

          -  Able to communicate in French or English

          -  Capable of providing informed consent

          -  Over 45 years old

          -  Subjective cognitive complaints

          -  Performance on objective computerized cognitive tests that falss at or below 50th
             percentile of performance in the cohort (main study) as a whole)

        Exclusion Criteria:

          -  Presence of dementia

          -  Life expectancy of 3 years or less

          -  Other neurological disorder including opportunistic CNS infection, psychotic disorder

          -  Current substance dependence or abuse

          -  Hepatitis C requiring interferon therapy during the study period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>46 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Josee Brouillette, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University Health Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lesley Fellows, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique Medicale L'Actuel</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4P9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McGill University Health Center</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2017</study_first_submitted>
  <study_first_submitted_qc>May 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2017</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University</investigator_affiliation>
    <investigator_full_name>Marie-Jos√©e Brouillette</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Cognition</keyword>
  <keyword>Intervention</keyword>
  <keyword>Self-management</keyword>
  <keyword>Rehabilitation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

